from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0225/-

LFCtreatmentdescriptionclass of inhibitor

-0.656

Amikacinug/mL Amikacintranslation

-1.650

Cap5-10ug/mL Capreomycintranslation

-1.009

Rox10-50 ug/mL Roxithromycintranslation

-0.031

SM2-5 ug/mL Streptomycintranslation

-2.474

Tet5-10 ug/mL Tetracyclinetranslation

0.431

Rif0.2-5ug/mL Rifampicintranscription

0.726

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.055

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-3.012

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.327

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.094

Clofazimine10-13 ug/mL Clofaziminerespiration

0.350

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.202

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.084

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.967

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.101

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.240

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.174

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.604

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.377

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.186

KCN5-20 ug/mL Potassium cyaniderespiration

0.465

NaN30.2-2 mM Sodium aziderespiration

-0.365

Nigericin50 uM Nigericinrespiration

-0.413

TRC10-150 ug/mL Triclosanrespiration

-0.498

TRZ10-25 ug/mL Thioridazinerespiration

-1.729

Valinomycin0.5-10 uM Valinomycinrespiration

1.017

ZnSO42 mM ZnSO4respiration

0.103

menadione6-10 ug/mL Menadionerespiration

0.333

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.745

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.279

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.703

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.578

NRP_1Non-replicating persistence stage 1dosRassociated

0.523

Amp0.2mg/mL AmpicillincellWall

0.401

Cephalexin20-100 ug/mL CephalexincellWall

0.141

Cerulenin0.32-5 ug/mL CerulenincellWall

0.364

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.416

EMB10-20 ug/mL EthambutolcellWall

0.619

Eta12-40 ug/mL EthionamidecellWall

1.265

INH0.2-0.4 ug/mL IsoniazidcellWall

0.657

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.010

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.579

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.326

BZA0.12 mg/mL BenzamidearomaticAmides

0.492

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.496

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.373

H2O24 mM hydrogen peroxideDNAdamaging

0.372

Levo10 ug/mL LevofloxacinDNAdamaging

0.406

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.007

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.084

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.540

UVUV-irradiationDNAdamaging

-1.493

ARP41-4 ug/mL Antitubercular compound ARP4?

0.712

Antimycin12.5-50 ug/mL Antimycin A?

0.402

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.174

PA_110-50 ug/mL Antitubercular compound PA-1?

0.834

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.023

PA8240.2-2 ug/mL PA-824?

-0.974

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.226

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.452

Verapamil50 uM Verapamil?

0.037

mercaptoethanol2 mM 2-Mercaptoethanol?

0.099

methoxatin10-20 ug/mL Methoxatin?